Alumni raised $1.45B in 2022 - Download Free Report Now

Alucent Biomedical

Congratulations to Alucent Biomedical on being selected as an Innovation Leader at LSI’s Emerging Medtech Summit 2020.

Purchase 2020 Summit (digital) Get info on 2021 Summit (in-person)
Myles

Myles Greenberg

CEO & President

Alucent Biomedical

Photoactivated drug-device combination therapy for patients with peripheral vascular disease

Share

Coming Soon

Our Clients

0-Minnetronix.png
1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
5-mckinsey.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.png
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.png
hospira.png
jlabs.png
kimberlyclark.png
merck.png
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
tecan.png
teleflex.png
terumo.png
zimmerbiomet.png